Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010. - Wikidata - awgldk - TriplyDB

Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010.

Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010.

http://www.wikidata.org/entity/Q34418688

about

Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use.A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's disease Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjects.Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics.Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital.

P2860

Q35948858-DF22505B-09E1-4F58-8D6A-97C95F3D1C83 Q37184470-74C4AC99-7486-4956-8CF9-BF5D4C0CF888 Q37587289-8F092539-ACD8-4D90-8647-24EA449717F6 Q38734067-869EF676-891E-482C-89F5-E970331D2014 Q50674482-5F11EE94-CD67-425A-B9A0-FF0CE6E3C27F

P2860

Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010.

http://www.wikidata.org/entity/Q34418688

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Plasma amisulpride in relation ...... monitoring service, 2002-2010.

@ast

Plasma amisulpride in relation ...... monitoring service, 2002-2010.

@en

Plasma amisulpride in relation ...... monitoring service, 2002-2010.

@nl

type

label

Plasma amisulpride in relation ...... monitoring service, 2002-2010.

@ast

Plasma amisulpride in relation ...... monitoring service, 2002-2010.

@en

Plasma amisulpride in relation ...... monitoring service, 2002-2010.

@nl

prefLabel

Plasma amisulpride in relation ...... monitoring service, 2002-2010.

@ast

Plasma amisulpride in relation ...... monitoring service, 2002-2010.

@en

Plasma amisulpride in relation ...... monitoring service, 2002-2010.

@nl

P1433

Q34418688-A46A4F2F-CBE9-4717-BE1E-4DF47D5B6BB8

P1476

Q34418688-B2903172-DE61-458C-A921-BFE0C384B0B6

P2093

Q34418688-0C2FB6D5-F9A1-47B2-AE67-4724CCBC881F

Q34418688-3082246A-DF04-4B7E-B974-DEC7E9A1BB5A

Q34418688-844CE7FB-BDB5-4708-9C84-51D53B8D836D

Q34418688-DA8A5B12-7E38-4BEE-965D-F4816148D5D4

P2860

Q34418688-018DB736-B8AE-4379-89F0-F51599618C79

Q34418688-0407B5A2-2B54-476F-BDA3-3DC234430263

Q34418688-1A8E1686-E4D2-47F2-AB32-8C2ED6A09E75

Q34418688-25E9FC00-41B9-4AD5-8666-94F9D9D90032

Q34418688-3555F16A-F152-40AA-951A-6E2511882A30

Q34418688-3BFC2FC5-E1DE-40EC-ACE3-53F1F4896F2D

Q34418688-3E515EF6-D9AA-4528-BDF5-983221031D3B

Q34418688-41CC4ABD-E34C-434F-947F-F51EAC3B9530

Q34418688-4A8AF40F-8A5E-4E35-B221-83613CD31718

Q34418688-59132206-C7CF-4772-B187-740D80FCCA59

P304

Q34418688-65DFACA3-EBE8-45B1-BA32-F395D95C03B1

P31

Q34418688-54000706-B81B-4804-A36C-6447BA3437E9

P356

Q34418688-1AC99DAB-5F3F-4F6D-A9B8-38D457A69C11

P433

Q34418688-34AE1A51-1D9B-4433-A087-A425A22748BE

P478

Q34418688-7FEC82C8-418B-452C-B60D-368E00A2935D

P577

Q34418688-C8FB6A08-B471-406B-A294-766EB341D0BF

P698

Q34418688-44C3D8FD-BC09-4537-A591-1CE28FBFFD03

P356

P1433

Human Psychopharmacology

P1476

Plasma amisulpride in relation ...... monitoring service, 2002-2010.

@en

P2093

Maxine X Patel

http://www.w3.org/2001/XMLSchema#string

Robert J Flanagan

http://www.w3.org/2001/XMLSchema#string

Sally V J Bowskill

http://www.w3.org/2001/XMLSchema#string

Simon A Handley

http://www.w3.org/2001/XMLSchema#string

P2860

A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers

Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial

Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine

Biotransformation of Post-Clozapine Antipsychotics

Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007.

Plasma olanzapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1999-2009.

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology.

Relationship between P-glycoprotein and second-generation antipsychotics.

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.

Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring.

P304

507-513

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HUP.2256

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22996618

http://www.w3.org/2001/XMLSchema#string